The “value” of immune-checkpoint inhibitors for advanced lung cancer

Akira Inoue

doi:10.1016/j.resinv.2017.04.001

The “value” of immune-checkpoint inhibitors for advanced lung cancer

MED - Medical Sciences

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	253-254
Number of pages	2
Journal	Respiratory Investigation
Volume	55
Issue number	4
DOIs	https://doi.org/10.1016/j.resinv.2017.04.001
Publication status	Published - 2017 Jul

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.resinv.2017.04.001

Cite this

@article{a60fd2adee2743ab9233b8ed621dac0a,

title = "The “value” of immune-checkpoint inhibitors for advanced lung cancer",

author = "Akira Inoue",

year = "2017",

month = jul,

doi = "10.1016/j.resinv.2017.04.001",

language = "English",

volume = "55",

pages = "253--254",

journal = "Respiratory Investigation",

issn = "2212-5345",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - The “value” of immune-checkpoint inhibitors for advanced lung cancer

AU - Inoue, Akira

PY - 2017/7

Y1 - 2017/7

UR - http://www.scopus.com/inward/record.url?scp=85020123686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020123686&partnerID=8YFLogxK

U2 - 10.1016/j.resinv.2017.04.001

DO - 10.1016/j.resinv.2017.04.001

M3 - Editorial

C2 - 28705302

AN - SCOPUS:85020123686

VL - 55

SP - 253

EP - 254

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - 4

ER -

The “value” of immune-checkpoint inhibitors for advanced lung cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this